Steadily advancing internationalization is a key component of our long-term development strategy. We consistently emphasize efficient and groundbreaking R&D innovation, balancing independent development with open collaboration. By integrating global resources and strengthening international partnerships, we build on our foundation of internal driving growth to achieve broader progress.

We remain committed to innovation, focusing on research from the source of technology. Through relentless exploration, we have established a global patent portfolio in areas such as innovative drug development, long-acting peptide drugs, and generic drug research. We are accelerating global market expansion, entering emerging markets, and actively pursuing external collaborations involving proprietary intellectual property. Our goal is to promote Chinese innovative drugs on the global stage.